Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Austin

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Cell Stem Cell|December 27, 2016
Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation CarriersMingxia Gu, Ning-Yi Shao, Silin Sa, et al.
JACC. Basic to Translational Science|December 14, 2023
Development of a Peripherally Restricted 5-HT<sub>2B</sub> Partial Agonist for Treatment of Pulmonary Arterial HypertensionMichael S Valentine, Aaron M Bender, Sheila Shay, et al.
The American Journal of Medicine|February 9, 2018
Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial HypertensionMorgan E Whitaker, Vineet Nair, Shripad Sinari, et al.
The Journal of Pediatrics|October 25, 2025
Pulmonary Hemodynamics and Long-Term Outcomes in Children with Pulmonary Hypertension-Associated Bronchopulmonary DysplasiaEric D Austin, Mary P Mullen, Catherine M Avitabile, et al.
Pediatric Pulmonology|March 13, 2021
Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United StatesJoseph M Collaco, Amit Agarwal, Eric D Austin, et al.
The Journal of Pediatrics|December 26, 2015
Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary HypertensionJohn P Kinsella, Robin H Steinhorn, Usha S Krishnan, et al.
The Journal of Clinical Investigation|May 3, 2017
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunctionChrista F Gaskill, Erica J Carrier, Jonathan A Kropski, et al.
American Journal of Respiratory and Critical Care Medicine|November 11, 2022
Molecular Function and Contribution of <i>TBX4</i> in Development and DiseaseJustyna A Karolak, Carrie L Welch, Christian Mosimann, et al.
Pulmonary Circulation|July 7, 2017
Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionRobert A Egnatchik, Evan L Brittain, Amy T Shah, et al.
The European Respiratory Journal|June 2, 2019
Phenotype characterisation of <i>TBX4</i> mutation and deletion carriers with neonatal and paediatric pulmonary hypertensionCsaba Galambos, Mary P Mullen, Joseph T Shieh, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Cell Stem Cell|December 27, 2016
Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation CarriersMingxia Gu, Ning-Yi Shao, Silin Sa, et al.
JACC. Basic to Translational Science|December 14, 2023
Development of a Peripherally Restricted 5-HT<sub>2B</sub> Partial Agonist for Treatment of Pulmonary Arterial HypertensionMichael S Valentine, Aaron M Bender, Sheila Shay, et al.
The American Journal of Medicine|February 9, 2018
Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial HypertensionMorgan E Whitaker, Vineet Nair, Shripad Sinari, et al.
The Journal of Pediatrics|October 25, 2025
Pulmonary Hemodynamics and Long-Term Outcomes in Children with Pulmonary Hypertension-Associated Bronchopulmonary DysplasiaEric D Austin, Mary P Mullen, Catherine M Avitabile, et al.
Pediatric Pulmonology|March 13, 2021
Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United StatesJoseph M Collaco, Amit Agarwal, Eric D Austin, et al.
The Journal of Pediatrics|December 26, 2015
Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary HypertensionJohn P Kinsella, Robin H Steinhorn, Usha S Krishnan, et al.
The Journal of Clinical Investigation|May 3, 2017
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunctionChrista F Gaskill, Erica J Carrier, Jonathan A Kropski, et al.
American Journal of Respiratory and Critical Care Medicine|November 11, 2022
Molecular Function and Contribution of <i>TBX4</i> in Development and DiseaseJustyna A Karolak, Carrie L Welch, Christian Mosimann, et al.
Pulmonary Circulation|July 7, 2017
Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionRobert A Egnatchik, Evan L Brittain, Amy T Shah, et al.
The European Respiratory Journal|June 2, 2019
Phenotype characterisation of <i>TBX4</i> mutation and deletion carriers with neonatal and paediatric pulmonary hypertensionCsaba Galambos, Mary P Mullen, Joseph T Shieh, et al.
Pageof 18